The decline follows a $500m cut in grant support by the US HHS.
Venture financing for mRNA-based innovator vaccines declined by 82% from $510m in 2023 to $90m year-to-date (YTD) in 2025, according to GlobalData.
The decline follows a $500m cut…
The decline follows a $500m cut in grant support by the US HHS.
Venture financing for mRNA-based innovator vaccines declined by 82% from $510m in 2023 to $90m year-to-date (YTD) in 2025, according to GlobalData.
The decline follows a $500m cut…